Aurinia Pharmaceuticals Company Profile (NASDAQ:AUPH)

About Aurinia Pharmaceuticals

Aurinia Pharmaceuticals logoAurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Company's primary business is the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis (LN). It is focused on the development of its lead compound voclosporin, a therapeutic immunomodulating drug candidate, which is a second-generation calcineurin inhibitors (CNI) to treat patients afflicted with LN. Voclosporin is an oral drug, administered twice daily. It is structurally similar to cyclosporine A (CsA), but is chemically modified on the amino acid-1 residue. It has completed two Phase III clinical studies in patients with moderate to severe psoriasis. It has completed Phase IIb clinical trial, which is a randomized, controlled, double-blind study comparing the efficacy of voclosporin as a component of multi-targeted therapy against placebo in achieving remission in patients with active LN.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AUPH
  • CUSIP:
Key Metrics:
  • Previous Close: $2.90
  • 50 Day Moving Average: $3.15
  • 200 Day Moving Average: $2.96
  • 52-Week Range: $1.42 - $5.69
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -5.09
  • P/E Growth: 0.00
  • Market Cap: $113.22M
  • Outstanding Shares: 39,727,000
  • Beta: 2.86
Profitability:
  • Net Margins: -9,512.50%
  • Return on Equity: -109.61%
  • Return on Assets: -66.44%
Debt:
  • Current Ratio: 3.64%
  • Quick Ratio: 3.64%
Additional Links:
Companies Related to Aurinia Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Aurinia Pharmaceuticals (NASDAQ:AUPH) (?)
Ratings Breakdown: 6 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $8.80 (208.77% upside)

Analysts' Ratings History for Aurinia Pharmaceuticals (NASDAQ:AUPH)
Show:
DateFirmActionRatingPrice TargetDetails
12/4/2016Leerink SwannReiterated RatingOutperform$7.00View Rating Details
11/4/2016Bloom BurtonReiterated RatingBuyView Rating Details
11/8/2016HC WainwrightReiterated RatingBuy$10.00View Rating Details
11/4/2016FBR & CoReiterated RatingOutperform$9.00View Rating Details
11/2/2016MackieReiterated RatingBuy$8.00View Rating Details
10/8/2016Canaccord GenuityReiterated RatingBuy$10.00View Rating Details
5/8/2015MLV & Co.Initiated CoverageBuy$9.00View Rating Details
(Data available from 12/9/2014 forward)

Earnings

Earnings History for Aurinia Pharmaceuticals (NASDAQ:AUPH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/31/2015($0.11)($0.15)ViewN/AView Earnings Details
11/12/2014Q3 14($0.08)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Aurinia Pharmaceuticals (NASDAQ:AUPH)
Current Year EPS Consensus Estimate: $-0.54 EPS
Next Year EPS Consensus Estimate: $-0.56 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.14)($0.14)($0.14)
Q2 20161($0.15)($0.15)($0.15)
Q3 20162($0.15)($0.12)($0.14)
Q4 20162($0.13)($0.10)($0.12)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Aurinia Pharmaceuticals (NASDAQ:AUPH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Aurinia Pharmaceuticals (NASDAQ:AUPH)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Aurinia Pharmaceuticals (NASDAQ:AUPH)
DateHeadline
News IconAurinia Pharmaceuticals Inc (NASDAQ:AUPH) Earnings Seen At $-0.11 - Stock Observer (NASDAQ:AUPH)
www.thestockobserver.com - November 25 at 3:45 PM
News IconTrending Stock - Aurinia Pharmaceuticals Inc.'s (AUPH) - Hot Stocks Point (NASDAQ:AUPH)
www.hotstockspoint.com - November 25 at 3:45 PM
News IconAurinia Pharmaceuticals Inc (NASDAQ:AUPH) touched its 52-Week High on Oct 6, 2016 - The Newburgh Press (NASDAQ:AUPH)
newburghpress.com - November 23 at 9:42 PM
News IconReady for a Move? Technicals in Focus for Aurinia Pharmaceuticals Inc. (AUPH) - MicroCap Wired (NASDAQ:AUPH)
www.microcapwired.com - November 23 at 3:44 PM
News IconInvestor Notebook: Focusing in on Shares of Aurinia Pharmaceuticals Inc. (AUPH) - Yankee Analysts (NASDAQ:AUPH)
yankeeanalysts.com - November 23 at 12:28 PM
streetinsider.com logoAurinia Pharmaceuticals (AUPH) Announces Late-Breaking Presentation of Voclosporin Phase IIb AURA Data; Primary Endpoint Met (NASDAQ:AUPH)
www.streetinsider.com - November 22 at 1:46 PM
News IconInvestor Probe: Watching Technicals for Aurinia Pharmaceuticals Inc. (AUPH) - Yankee Analysts (NASDAQ:AUPH)
yankeeanalysts.com - November 21 at 3:33 PM
streetinsider.com logoAurinia Pharmaceuticals (AUPH) Announces Late-Breaking Presentation of Voclosporin Phase IIb AURA Data; Primary ... - StreetInsider.com (NASDAQ:AUPH)
www.streetinsider.com - November 21 at 3:33 PM
finance.yahoo.com logo9:31 am Aurinia Pharma provides highlights from its Phase IIb AURA study of voclosporin in the treatment of lupus nephritis presented at the American Society of Nephrology Kidney Week 2016 (NASDAQ:AUPH)
finance.yahoo.com - November 21 at 3:33 PM
News IconShares in Focus: Aurinia Pharmaceuticals Inc. (AUPH) - Yankee Analysts (NASDAQ:AUPH)
yankeeanalysts.com - November 20 at 3:35 PM
stocksdaily.net logoAurinia Pharmaceuticals Inc (NASDAQ:AUPH) EPS Target Set At $-0.11 - Stocks Daily (NASDAQ:AUPH)
www.stocksdaily.net - November 19 at 3:40 PM
News IconFinancial Update of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) - The Newburgh Press (NASDAQ:AUPH)
newburghpress.com - November 18 at 3:40 PM
News IconFocusing on the Numbers for Aurinia Pharmaceuticals Inc. (AUPH) - MicroCap Wired (NASDAQ:AUPH)
www.microcapwired.com - November 18 at 3:40 PM
smarteranalyst.com logoStock Update (NASDAQ:AUPH): Aurinia Pharmaceuticals Inc ... - Smarter Analyst (NASDAQ:AUPH)
www.smarteranalyst.com - November 18 at 3:40 PM
News IconAurinia Pharmaceuticals Aligns with FDA on Lupus Drug (AUPH) (NASDAQ:AUPH)
sostrenews.com - November 17 at 8:14 PM
4-traders.com logoAurinia Pharmaceuticals : Highlights Speed of Remission from Global Phase IIb AURA Study of Voclosporin in LN (NASDAQ:AUPH)
www.4-traders.com - November 17 at 1:15 PM
investopedia.com logoAurinia Aligns with FDA on Lupus Drug (AUPH) (NASDAQ:AUPH)
www.investopedia.com - November 17 at 1:15 PM
businesswire.com logoAurinia Highlights Speed of Remission from Global Phase IIb AURA Study of Voclosporin in Lupus Nephritis at 2016 American College of Rheumatology Annual Meeting (NASDAQ:AUPH)
www.businesswire.com - November 16 at 1:02 PM
publicnow.com logoAurinia Highlights Speed of Remission from Global Phase IIb AURA Study of Voclosporin in LN (NASDAQ:AUPH)
www.publicnow.com - November 16 at 1:02 PM
finance.yahoo.com logoAurinia Pharmaceuticals Rises on Positive Mid-Stage Update (NASDAQ:AUPH)
finance.yahoo.com - November 16 at 1:02 PM
News IconWatching the Charts on Aurinia Pharmaceuticals Inc. (AUPH) - Yankee Analysts (NASDAQ:AUPH)
yankeeanalysts.com - November 15 at 3:48 PM
News IconAurinia Pharmaceuticals Inc.'s (AUPH): Trader's Focus - Hot Stocks Point (NASDAQ:AUPH)
www.hotstockspoint.com - November 15 at 3:48 PM
News IconTechnicals in Focus for Aurinia Pharmaceuticals Inc. (AUPH) - MicroCap Wired (NASDAQ:AUPH)
www.microcapwired.com - November 11 at 8:25 PM
News IconAurinia Pharmaceuticals Inc (NASDAQ:AUPH) Performance ... - The Newburgh Press (NASDAQ:AUPH)
newburghpress.com - November 11 at 8:25 PM
News IconStock Grabbing Investor's Attention: Aurinia Pharmaceuticals Inc ... - Post Registrar (NASDAQ:AUPH)
postregistrar.com - November 11 at 8:25 PM
News IconNew Analyst Ratings On Aurinia Pharmaceuticals Inc (AUPH) - NewsDen (NASDAQ:AUPH)
newsden.net - November 10 at 9:49 PM
News IconMA Levels in Review for Aurinia Pharmaceuticals Inc. (AUPH) - MicroCap Wired (NASDAQ:AUPH)
www.microcapwired.com - November 10 at 9:49 PM
finance.yahoo.com logoAurinia Pharmaceuticals to Present at Stifel 2016 Healthcare Conference (NASDAQ:AUPH)
finance.yahoo.com - November 10 at 2:13 PM
smarteranalyst.com logoHC Wainwright Believes Aurinia Pharmaceuticals Inc (AUPH) Wins Big with Results of End-of-Phase 2 Meeting with FDA - Smarter Analyst (NASDAQ:AUPH)
www.smarteranalyst.com - November 9 at 10:17 PM
smarteranalyst.com logoStock Update (NASDAQ:AUPH): Aurinia Pharmaceuticals Inc Establishes At-The-Market Facility - Smarter Analyst (NASDAQ:AUPH)
www.smarteranalyst.com - November 9 at 10:17 PM
News IconWilliams %R Check on Shares of Aurinia Pharmaceuticals Inc. (AUPH) - MicroCap Wired (NASDAQ:AUPH)
www.microcapwired.com - November 9 at 12:35 PM
capitalcube.com logoAurinia Pharmaceuticals, Inc. :AUPH-US: Earnings Analysis: Q3, 2016 By the Numbers : November 8, 2016 (NASDAQ:AUPH)
www.capitalcube.com - November 8 at 2:22 PM
News IconLong Term Growth review of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) - The Newburgh Press (NASDAQ:AUPH)
newburghpress.com - November 7 at 1:36 PM
streetinsider.com logoAurinia Pharmaceuticals (AUPH) Misses Q3 EPS by 7c; Initiates Talks with Japan for Voclosporin Phase 1 - StreetInsider.com (NASDAQ:AUPH)
www.streetinsider.com - November 7 at 1:36 PM
News IconShares Knocked Down Over Past Month: Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - CSZ News (NASDAQ:AUPH)
cincysportszone.com - November 6 at 3:49 PM
investors.com logoAurinia Pharma and Bengal Energy are Spec Buy says Mackie (NASDAQ:AUPH)
www.proactiveinvestors.com - November 5 at 11:37 AM
News IconAurinia Reports Third Quarter 2016 Financial Results and Operational Highlights (NASDAQ:AUPH)
www.advfn.com - November 5 at 11:37 AM
News IconEquity Rundown: RSI and CCI Check on Aurinia Pharmaceuticals Inc. (AUPH) - MicroCap Wired (NASDAQ:AUPH)
www.microcapwired.com - November 4 at 9:01 PM
sg.finance.yahoo.com logoAurinia reports 3Q loss (NASDAQ:AUPH)
sg.finance.yahoo.com - November 4 at 9:01 PM
News IconEarnings Analysis & Update for Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)? - CSZ News (NASDAQ:AUPH)
cincysportszone.com - November 4 at 2:03 PM

Social

Aurinia Pharmaceuticals (NASDAQ:AUPH) Chart for Friday, December, 9, 2016


Last Updated on 12/9/2016 by MarketBeat.com Staff